Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

DGX

Quest Diagnostics, Inc

Dec 26 • 04:00PM ET

153.02

Dollar change -0.40
Percentage change -0.26	%

Healthcare • Diagnostics & Research • USA • NYSE

Peers: LH NEO EXAS OPK NTRA PMD

| Held by: VTI VOO VO SPY IVV VTV RSP VOE XLV VIG

Scroll to Statements

Index	S&P 500	P/E	20.54	EPS (ttm)	7.45	Insider Own	0.50%	Shs Outstand	112.00M	Perf Week	1.17%
Market Cap	17.08B	Forward P/E	15.73	EPS next Y	9.73	Insider Trans	-18.10%	Shs Float	111.06M	Perf Month	-5.80%
Income	838.00M	PEG	3.11	EPS next Q	2.19	Inst Own	89.56%	Short Float	1.72%	Perf Quarter	-0.91%
Sales	9.54B	P/S	1.79	EPS this Y	2.17%	Inst Trans	0.40%	Short Ratio	2.30	Perf Half Y	11.42%
Book/sh	60.79	P/B	2.52	EPS next Y	9.32%	ROA	5.67%	Short Interest	1.91M	Perf Year	11.89%
Cash/sh	6.84	P/C	22.36	EPS next 5Y	6.60%	ROE	12.66%	52W Range	123.04 - 165.32	Perf YTD	10.98%
Dividend Est.	2.92 (1.91%)	P/FCF	16.70	EPS past 5Y	7.36%	ROI	6.45%	52W High	-7.44%	Beta	0.89
Dividend TTM	2.96 (1.93%)	Quick Ratio	1.17	Sales past 5Y	4.86%	Gross Margin	31.74%	52W Low	24.37%	ATR (14)	2.80
Dividend Ex-Date	Jan 14, 2025	Current Ratio	1.25	EPS Y/Y TTM	11.04%	Oper. Margin	14.15%	RSI (14)	41.08	Volatility	1.94% 1.74%
Employees	48000	Debt/Eq	1.02	Sales Y/Y TTM	2.60%	Profit Margin	8.78%	Recom	2.05	Target Price	173.13
Option/Short	Yes / Yes	LT Debt/Eq	0.91	EPS Q/Q	1.79%	Payout	37.76%	Rel Volume	0.53	Prev Close	153.42
Sales Surprise	2.39%	EPS Surprise	1.60%	Sales Q/Q	8.41%	Earnings	Oct 22 BMO	Avg Volume	828.84K	Price	153.02
SMA20	-2.30%	SMA50	-2.52%	SMA200	4.68%	Trades		Volume	443,193	Change	-0.26%

Date	Action	Analyst	Rating Change	Price Target Change
Dec-17-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$145 → $172
Dec-10-24	Resumed	Jefferies	Buy	$175 → $185
Oct-23-24	Upgrade	Robert W. Baird	Neutral → Outperform	$157 → $182
Aug-28-24	Resumed	Evercore ISI	In-line	$165
Jul-10-24	Upgrade	Citigroup	Neutral → Buy	$145 → $165
Feb-26-24	Initiated	Leerink Partners	Market Perform	$135
Feb-07-24	Upgrade	Jefferies	Hold → Buy	$140 → $155
Jan-03-24	Initiated	Barclays	Equal Weight	$145
Dec-12-23	Upgrade	BofA Securities	Neutral → Buy	$140 → $160
Jun-29-23	Initiated	Piper Sandler	Neutral
May-02-23	Downgrade	BofA Securities	Buy → Neutral	$166 → $148
Apr-03-23	Upgrade	Citigroup	Sell → Neutral	$125 → $142
Jan-23-23	Initiated	Evercore ISI	In-line	$159
Nov-17-22	Downgrade	Citigroup	Neutral → Sell	$145 → $125
Aug-22-22	Resumed	Morgan Stanley	Equal-Weight	$142
Apr-04-22	Downgrade	Citigroup	Buy → Neutral	$175 → $140
Feb-23-22	Downgrade	UBS	Buy → Neutral	$160 → $139
Feb-02-22	Downgrade	Jefferies	Buy → Hold	$135
Jan-28-22	Downgrade	Deutsche Bank	Buy → Hold	$190 → $129
May-04-21	Upgrade	UBS	Neutral → Buy	$135 → $158

Show Previous Ratings

Dec-23-24 12:30PM	Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management (ACCESSWIRE)
Dec-20-24 10:31AM	Mainz Biomed partners with Quest for colorectal cancer screening test (Medical Device Network)
Dec-19-24 08:01AM	Mainz Biomed Forms Agreement with Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test (GlobeNewswire)
Dec-17-24 03:10PM	Quest Diagnostics Advances Environmental Stewardship With Renewable Energy Initiatives, Waste Reduction, and ISO 14001 Certifications in 2023 (ACCESSWIRE)
Dec-03-24 09:50AM	Quest Diagnostics to Speak at the 7th Annual Evercore HealthCONx Conference (PR Newswire)
08:23AM	Loading…
08:23AM	Quest Diagnostics Launches Health Coaching on questhealth.com to Help Individuals Take Control of Their Health (PR Newswire)
Nov-28-24 05:30AM	Why Quest Diagnostics Incorporated (DGX) Is One of the Most Undervalued Pot Stocks to Buy? (Insider Monkey)
Nov-21-24 11:30AM	Quest Diagnostics (DGX) Up 2.7% Since Last Earnings Report: Can It Continue? (Zacks)
Nov-20-24 02:44PM	Guardant Health Stock Sees RS Rating Jump To 83 (Investor's Business Daily)
Nov-13-24 12:00PM	All You Need to Know About Quest Diagnostics (DGX) Rating Upgrade to Buy (Zacks)
Nov-12-24 05:57PM	Quest Diagnostics Declares Quarterly Cash Dividend (PR Newswire)
Oct-25-24 09:15AM	Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out? (Zacks)
Oct-24-24 01:06AM	Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight (GuruFocus.com)
Oct-23-24 07:53AM	Quest Diagnostics Awarded CDC Contracts for H5 Avian Influenza and Oropouche Virus Test Development (PR Newswire)
03:03AM	Quest Diagnostics Inc (DGX) Q3 2024 Earnings Call Highlights: Strong Revenue Growth Amid ... (GuruFocus.com)
11:49PM	Loading…
Oct-22-24 11:49PM	Q3 2024 Quest Diagnostics Inc Earnings Call (Thomson Reuters StreetEvents) +6.85%
05:22PM	S&P 500 Gains and Losses Today: GM Stock Pops as EVs and SUVs Drive Earnings Beat (Investopedia)
03:46PM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
07:55AM	Quest Diagnostics (DGX) Beats Q3 Earnings and Revenue Estimates (Zacks)
06:51AM	Quest Diagnostics: Q3 Earnings Snapshot (Associated Press Finance)
06:45AM	Quest Diagnostics Reports Third Quarter 2024 Financial Results; Updates Guidance for Full Year 2024 (PR Newswire)
Oct-16-24 09:40AM	Are Investors Undervaluing Quest Diagnostics (DGX) Right Now? (Zacks)
Oct-15-24 10:00AM	Quest Diagnostics (DGX) Earnings Expected to Grow: What to Know Ahead of Next Week's Release (Zacks)
08:04AM	Quest Diagnostics Introduces Specimen Self-Collection for Common Genital Tract Infection Testing at Nationwide Network of Patient Service Centers (PR Newswire)
Oct-14-24 08:50AM	Quest Diagnostics Completes Acquisition of Lab Assets from OhioHealth (PR Newswire)
Sep-30-24 09:40AM	Is Quest Diagnostics (DGX) Stock Undervalued Right Now? (Zacks)
Sep-25-24 11:24AM	Quest Diagnostics to Release Third Quarter 2024 Financial Results on October 22, 2024 (PR Newswire)
Sep-24-24 09:40AM	Here's Why Quest Diagnostics (DGX) is a Strong Value Stock (Zacks)
Sep-18-24 08:51AM	Sentara Health Plans and Quest Diagnostics Form Strategic Collaboration to Extend Lab Access in Parts of the Southeast (PR Newswire)
Sep-16-24 08:51AM	Quest Diagnostics Completes Acquisition of Select Lab Assets from Allina Health (PR Newswire)
09:40AM	Loading…
Sep-05-24 09:40AM	Why Quest Diagnostics (DGX) is a Top Value Stock for the Long-Term (Zacks)
Aug-30-24 09:40AM	Should Value Investors Buy Quest Diagnostics (DGX) Stock? (Zacks)
Aug-28-24 03:31PM	Quest Diagnostics to Speak at the Morgan Stanley 22nd Annual Global Healthcare Conference (PR Newswire)
Aug-27-24 08:23AM	Quest Diagnostics completes LifeLabs acquisition from OMERS (Medical Device Network)
Aug-26-24 08:50AM	Quest Diagnostics Completes Acquisition of LifeLabs, Enhancing Access to Diagnostic Innovation (PR Newswire)
08:31AM	Quest Diagnostics' (DGX) New Deal Aids Diagnostic Access in Ohio (Zacks)
Aug-23-24 07:53AM	Quest inks deal for University Hospitals outreach lab services (MedTech Dive)
Aug-22-24 11:30AM	Quest Diagnostics (DGX) Up 6.3% Since Last Earnings Report: Can It Continue? (Zacks)
10:35AM	Quest Diagnostics to buy University Hospitals outreach lab assets (Hospital Management)
09:15AM	Quest Diagnostics Incorporated (DGX) Hits Fresh High: Is There Still Room to Run? (Zacks)
Aug-21-24 08:55AM	Quest Diagnostics to Acquire University Hospitals' Outreach Laboratory Services Business (PR Newswire)
Aug-19-24 08:07AM	Quest Diagnostics (DGX) Debuts Micronutrient Deficiency Panels (Zacks)
Aug-16-24 06:33AM	Universal DX secures funding to advance Signal-C blood test trial (Medical Device Network)
Aug-15-24 06:13PM	Quest Diagnostics Prices $1.85 Billion of Senior Notes (PR Newswire)
09:05AM	Quest Diagnostics' (DGX) New Study Exposes Alarming Data on STI (Zacks)
07:32AM	questhealth.com Introduces 13 New Blood Tests to Identify Micronutrient Deficiencies (PR Newswire)
Aug-14-24 07:04PM	Quest Diagnostics Declares Quarterly Cash Dividend (PR Newswire)
09:40AM	Should Value Investors Buy Quest Diagnostics (DGX) Stock? (Zacks)
Aug-13-24 11:24AM	Quest Diagnostics (DGX) Gains From Innovation, Customer Wins (Zacks)
08:55AM	Should Quest Diagnostics (DGX) be in Your Portfolio Now? (Zacks)
Aug-12-24 08:51AM	Pregnant Women Undertested for STIs, Finds Quest Diagnostics Health Trends Study of Over 4 Million Pregnancies (PR Newswire)
Aug-11-24 07:37AM	The 'G' in ESG is gaining more shareholder love than the 'E' or 'S' (Yahoo Finance)
Aug-05-24 09:15AM	Quest Diagnostics Incorporated (DGX) Hit a 52 Week High, Can the Run Continue? (Zacks)
Aug-01-24 06:48AM	Quest Diagnostics Named a 'Best Place to Work for Disability Inclusion' for Seventh Straight Year (PR Newswire)
Jul-29-24 09:40AM	Are Investors Undervaluing Quest Diagnostics (DGX) Right Now? (Zacks)
08:03AM	Haystack Oncology and Universit de Montral's affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD Technology in Research Study for Metastatic Colorectal Cancer (PR Newswire)
Jul-26-24 01:04AM	Decoding Quest Diagnostics Inc (DGX): A Strategic SWOT Insight (GuruFocus.com)
Jul-25-24 06:45AM	BD, Quest Diagnostics Join Forces to Develop Companion Diagnostics for Cancer, Other Diseases (PR Newswire)
Jul-24-24 07:47AM	Quest Diagnostics' (DGX) Haystack Oncology Forges New MRD Deal (Zacks)
03:24AM	Analyst Report: Quest Diagnostics Incorporated (Morningstar Research)
12:21AM	Q2 2024 Quest Diagnostics Inc Earnings Call (Thomson Reuters StreetEvents)
Jul-23-24 10:05AM	Quest Diagnostics (DGX) Tops Q2 Earnings, Raises 2024 Outlook (Zacks)
07:55AM	Quest Diagnostics (DGX) Q2 Earnings and Revenues Top Estimates (Zacks)
06:51AM	Quest Diagnostics: Q2 Earnings Snapshot (Associated Press Finance)
06:45AM	Quest Diagnostics Reports Second Quarter 2024 Financial Results; Raises Guidance for Full Year 2024 (PR Newswire)
Jul-18-24 09:00AM	3 High Yield Healthcare Giants With Consistent Dividend Growth: Johnson & Johnson, Merck, And Quest Diagnostics (Benzinga)
08:00AM	Haystack Oncology and Lisata Therapeutics Initiate Research Collaboration to Use the Haystack MRD Technology to Evaluate Efficacy of Pancreatic Cancer Therapy (GlobeNewswire)
07:30AM	EXCLUSIVE: Haystack Oncology Inks Research Collaboration With Lisata Therapeutics To Use Haystack MRD Technology To Evaluate Pancreatic Cancer Therapy Efficacy (Benzinga)
Jul-17-24 09:50AM	Here's Why Quest Diagnostics (DGX) is a Strong Value Stock (Zacks)
06:00AM	Quest closing Pennsylvania lab, laying off 121 people (MedTech Dive)
Jul-16-24 09:15AM	Quest Diagnostics Incorporated (DGX) Soars to 52-Week High, Time to Cash Out? (Zacks)
Jul-15-24 08:35AM	Quest Diagnostics (DGX) Set to Acquire OhioHealth's Lab Services (Zacks)
06:17AM	Is Quest Diagnostics Incorporated (DGX) an Undervalued High Growth Stock? (Insider Monkey)
Jul-14-24 12:58PM	The Best Affordable Place to Live in New Jersey (Insider Monkey)
12:57PM	20 Best Affordable Places to Live in New Jersey (Insider Monkey)
Jul-12-24 09:37AM	What Awaits Quest Diagnostics (DGX) in Q2 Earnings Release? (Zacks)
Jul-11-24 10:55AM	Quest Diagnostics to purchase outreach lab assets from health system OhioHealth (Hospital Management)
Jul-10-24 08:58AM	Quest Diagnostics to Acquire Outreach Laboratory Services of OhioHealth (PR Newswire)
Jul-08-24 06:06AM	Quest to buy Lifelabs for $985M (MedTech Dive)
Jul-04-24 11:15AM	Quest Diagnostics (DGX) to Expand in Canada With LifeLabs Buyout (Zacks)
04:12AM	Quest Diagnostics to acquire Canadas LifeLabs for $985m (Medical Device Network)
Jul-03-24 08:45AM	Quest Diagnostics to Acquire LifeLabs from OMERS, Enhancing Diagnostic Services for Canadians (PR Newswire)
Jun-27-24 09:43AM	Quest Diagnostics (DGX) Inks Deal to Acquire Allina Health (Zacks)
06:45AM	Quest Diagnostics Releases 2023 Corporate Responsibility Report (PR Newswire)
Jun-26-24 04:03PM	Quest Diagnostics to Acquire Select Lab Assets from Allina Health (PR Newswire)
08:35AM	Is It Apt to Hold Quest Diagnostics (DGX) Stock for Now? (Zacks)
Jun-21-24 11:06AM	Quest Diagnostics (DGX) Gains From New M&As Amid Competition (Zacks)
Jun-19-24 03:00PM	Quest Diagnostics to Release Second Quarter 2024 Financial Results on July 23, 2024 (PR Newswire)
Jun-18-24 08:58AM	Quest Diagnostics' (DGX) New Buyout Ramps Up Cancer Diagnosis (Zacks)
Jun-12-24 11:15AM	My Quest Story - Mark Hamilton (ACCESSWIRE)
Jun-11-24 07:57AM	Quest Diagnostics Completes Acquisition of Select PathAI Diagnostics' Lab Assets from PathAI, Accelerating Adoption of AI and Digital Pathology to Speed Cancer Diagnosis (PR Newswire)
Jun-10-24 12:30PM	Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors (ACCESSWIRE)
Jun-06-24 10:15AM	Lab Week 2024 - Lisa Szeto-Tay (ACCESSWIRE)
Jun-05-24 12:10PM	Quest Diagnostics Grows Interest in Sustainability With Healthy NewsWorks Students (ACCESSWIRE)
May-31-24 04:08PM	Blood-based MRD Test for Cancer Recurrence Can Generate Cost Savings in Colorectal Cancer Treatment, Finds Study in JAMA Health Forum (PR Newswire)
May-29-24 12:20PM	Lab Week 2024 - Mimi Perdue-Loan (ACCESSWIRE)
May-23-24 11:30AM	Why Is Quest Diagnostics (DGX) Up 3.1% Since Last Earnings Report? (Zacks)
May-21-24 03:15PM	Ruth Clements Speaks at National Action Network Event Addressing Health Inequities (ACCESSWIRE)
01:15PM	Lab Week 2024 - Deepika Kumar (ACCESSWIRE)
May-16-24 04:15PM	Quest Diagnostics Elects Robert B. Carter, CIO of FedEx Corporation, to Board of Directors (PR Newswire)

Quest Diagnostics, Inc. engages in the provision of diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
PREVOZNIK MICHAEL E	SVP & General Counsel	Nov 29 '24	Option Exercise	86.63	35,146	3,044,698	73,624	Dec 02 04:43 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Nov 29 '24	Sale	163.07	35,146	5,731,302	38,478	Dec 02 04:43 PM
Doherty Catherine T.	EVP, Regional Businesses	Nov 27 '24	Option Exercise	103.57	33,103	3,428,478	101,515	Dec 02 04:41 PM
Doherty Catherine T.	EVP, Regional Businesses	Nov 27 '24	Sale	162.99	33,103	5,395,484	68,412	Dec 02 04:41 PM
PREVOZNIK MICHAEL E	Officer	Nov 29 '24	Proposed Sale	163.07	35,146	5,731,302		Nov 29 02:42 PM
Doherty Catherine T.	Officer	Nov 27 '24	Proposed Sale	162.99	33,103	5,395,484		Nov 27 04:12 PM
DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Nov 06 '24	Option Exercise	68.66	18,755	1,287,634	53,696	Nov 07 05:21 PM
DEPPE MICHAEL J	SVP, Corp. Controller & CAO	Nov 06 '24	Sale	154.05	18,755	2,889,123	34,941	Nov 07 05:21 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Oct 28 '24	Sale	156.92	1,775	278,525	9,734	Oct 30 04:26 PM
KUPPUSAMY KARTHIK	Officer	Oct 28 '24	Proposed Sale	156.87	1,775	278,450		Oct 28 12:51 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Aug 29 '24	Option Exercise	95.80	32,551	3,118,223	71,029	Sep 03 04:30 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Aug 29 '24	Sale	154.97	32,551	5,044,516	38,478	Sep 03 04:30 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Aug 28 '24	Sale	153.26	1,990	304,990	11,459	Aug 29 04:45 PM
PREVOZNIK MICHAEL E	Officer	Aug 29 '24	Proposed Sale	154.97	32,551	5,044,516		Aug 29 01:55 PM
KUPPUSAMY KARTHIK	Officer	Aug 28 '24	Proposed Sale	153.26	1,990	304,990		Aug 28 04:49 PM
DELANEY MARK E	SVP & Chief Commercial Officer	Jul 24 '24	Sale	143.08	420	60,094	5,019	Jul 26 06:33 PM
KUPPUSAMY KARTHIK	SVP, Clinical Solutions	Apr 29 '24	Sale	140.00	1,760	246,400	13,435	May 01 04:26 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 28 '24	Sale	126.57	5,557	703,349	69,599	Mar 01 04:51 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 29 '24	Sale	125.88	1,187	149,420	68,412	Mar 01 04:51 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Feb 29 '24	Sale	125.88	5,611	706,313	38,478	Mar 01 04:50 PM
PREVOZNIK MICHAEL E	SVP & General Counsel	Feb 22 '24	Sale	126.14	661	83,379	40,206	Feb 23 04:35 PM
Gregg Vicky B	Director	Feb 23 '24	Sale	126.64	2,500	316,596	16,329	Feb 23 04:34 PM
Doherty Catherine T.	EVP, Regional Businesses	Feb 22 '24	Sale	126.14	821	103,561	70,800	Feb 23 04:32 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DGX

Quest Diagnostics, Inc

Upgrade your FINVIZ experience